Morningstar Reports

12/04/2024

1 vote, average: 3.00 out of 51 vote, average: 3.00 out of 51 vote, average: 3.00 out of 51 vote, average: 3.00 out of 51 vote, average: 3.00 out of 5

BlackRock Continues to Lose Ground on the ETF Flow Front Despite Improving Equity and Credit Markets

BlackRock Inc

Greggory Warren, CFA
Strategist

09/04/2024

1 vote, average: 3.00 out of 51 vote, average: 3.00 out of 51 vote, average: 3.00 out of 51 vote, average: 3.00 out of 51 vote, average: 3.00 out of 5

Consumer Interest in Sailing Carnival Brands Buoyed Beyond Pent-Up Pandemic Demand

Carnival Corp

Jaime M. Katz, CFA
Senior Equity Analyst

09/04/2024

1 vote, average: 2.00 out of 51 vote, average: 2.00 out of 51 vote, average: 2.00 out of 51 vote, average: 2.00 out of 51 vote, average: 2.00 out of 5

Taiwan Semiconductor Projects Exciting 20% Sales Growth, Signaling Sector Recovery

Taiwan Semiconductor Manufacturing Co Ltd

Phelix Lee
Equity Analyst

08/04/2024

1 vote, average: 3.00 out of 51 vote, average: 3.00 out of 51 vote, average: 3.00 out of 51 vote, average: 3.00 out of 51 vote, average: 3.00 out of 5

AB InBev Could Soon Benefit From Margin Rebuild and Weaker US Dollar

Anheuser-Busch InBev SA/NV

Ioannis Pontikis, CFA
Senior Equity Analyst

05/04/2024

1 vote, average: 3.00 out of 51 vote, average: 3.00 out of 51 vote, average: 3.00 out of 51 vote, average: 3.00 out of 51 vote, average: 3.00 out of 5

Tesla’s Strategic Focus Shifts From Growth to Development of Affordable Vehicle and Cost Reductions

Tesla Inc

Seth Goldstein, CFA
Strategist

05/04/2024

1 vote, average: 3.00 out of 51 vote, average: 3.00 out of 51 vote, average: 3.00 out of 51 vote, average: 3.00 out of 51 vote, average: 3.00 out of 5

J&J’s Diverse Portfolio of Innovative Healthcare Products Sets Up Steady Long-Term Growth

Johnson & Johnson

Damien Conover, CFA
Sector Director

05/04/2024

1 vote, average: 3.00 out of 51 vote, average: 3.00 out of 51 vote, average: 3.00 out of 51 vote, average: 3.00 out of 51 vote, average: 3.00 out of 5

J&J’s Diverse Portfolio of Innovative Healthcare Products Sets Up Steady Long-Term Growth

Johnson & Johnson

Damien Conover, CFA
Sector Director

05/04/2024

1 vote, average: 3.00 out of 51 vote, average: 3.00 out of 51 vote, average: 3.00 out of 51 vote, average: 3.00 out of 51 vote, average: 3.00 out of 5

3M on Better Financial Footing Following Solventum Spinoff, but Must Demonstrate Better Results

3M Co

Joshua Aguilar
Senior Equity Analyst